Pancreatic Polypeptide Meal Response May Predict Gastric Band-Induced Weight Loss
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adrian TE, Bloom SR, Bryant MG, et al. Distribution and release of human pancreatic polypeptide. Gut. 1976;17:940–4.
Adrian TE, Ferri GL, Bacarese-Hamilton AJ, et al. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985;89:1070–7.
Jayasena CN, Bloom SR. Role of gut hormones in obesity. Endocrinol Metab Clin North Am. 2008;37:769–87. xi.
Neary NM, McGowan BM, Monteiro MP, et al. No evidence of an additive inhibitory feeding effect following PP and PYY 3–36 administration. Int J Obes (Lond). 2008;32:1438–40.
Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941–8.
le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 2006;147:3–8.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.
O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.
le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108–14.
Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359–65.
Shak JR, Roper J, Perez-Perez GI, et al. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg. 2008;18:1089–96.
Hanusch-Enserer U, Ghatei MA, Cauza E, et al. Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery. Wien Klin Wochenschr. 2007;119:291–6.
Bose M, Machineni S, Olivan B, et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring). 2010;18:1085–91.
Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond). 2009;33:786–95.
Dixon AF, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab. 2005;90:813–9.
Adrian TE, Bloom SR, Bryant MG, et al. Proceedings: radioimmunoassay of a new gut hormone-human pancreatic polypeptide. Gut. 1976;17:393–4.
Faraj M, Havel PJ, Phelis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–602.
Morinigo R, Vidal J, Lacy AM, et al. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg. 2008;247:270–5.
Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond). 2008;32:1640–6.
Adrian TE, Besterman HS, Cooke TJ, et al. Mechanism of pancreatic polypeptide release in man. Lancet. 1977;1:161–3.
Taylor IL, Feldman M. Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans. J Clin Endocrinol Metab. 1982;55:1114–7.
Kronborg O. Truncal vagotomy and drainage in 500 patients with duodenal ulcer. Scand J Gastroenterol. 1971;6:501–9.
Goligher JC, Pulvertaft CN, Irvin TT, et al. Five- to eight-year results of truncal vagotomy and pyloroplasty for duodenal ulcer. Br Med J. 1972;1:7–13.
Kral JG, Gortz L, Hermansson G, et al. Gastroplasty for obesity: long-term weight loss improved by vagotomy. World J Surg. 1993;17:75–8. discussion, 9.
Angrisani L, Cutolo PP, Ciciriello MB, et al. Laparoscopic adjustable gastric banding with truncal vagotomy versus laparoscopic adjustable gastric banding alone: interim results of prospective randomized trial. Surg Obes Relat Dis. 2009;5:435–8.
Camilleri M, Toouli J, Herrera MF, et al. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008;143:723–31.
Business Wire. EnteroMedics announces preliminary results of its EMPOWER(TM) study. http://ir.enteromedics.com/releasedetail.cfm?ReleaseID=413254 (2009). Accessed 31 December 2010.
Koren MS, Holmes MD. Vagus nerve stimulation does not lead to significant changes in body weight in patients with epilepsy. Epilepsy Behav. 2006;8:246–9.
Burneo JG, Faught E, Knowlton R, et al. Weight loss associated with vagus nerve stimulation. Neurology. 2002;59:463–4.
Bugajski AJ, Gil K, Ziomber A, et al. Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol. 2007;58 Suppl 1:5–12.
Laskiewicz J, Krolczyk G, Zurowski G, et al. Effects of vagal neuromodulation and vagotomy on control of food intake and body weight in rats. J Physiol Pharmacol. 2003;54:603–10.
Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res. 2003;11:1456–62.
Cigaina V, Hirschberg AL. Plasma ghrelin and gastric pacing in morbidly obese patients. Metabolism. 2007;56:1017–21.
Bohdjalian A, Prager G, Aviv R, et al. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg. 2006;16:627–34.
Luo J, Al-Juburi A, Rashed H, et al. Gastric electrical stimulation is associated with improvement in pancreatic exocrine function in humans. Pancreas. 2004;29:e41–4.
Koska J, DelParigi A, de Courten B, et al. Pancreatic polypeptide is involved in the regulation of body weight in pima Indian male subjects. Diabetes. 2004;53:3091–6.
Pfluger PT, Kampe J, Castaneda TR, et al. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab. 2007;92:583–8.
Alderdice JT, Dinsmore WW, Buchanan KD, et al. Gastrointestinal hormones in anorexia nervosa. J Psychiatr Res. 1985;19:207–13.
Uhe AM, Szmukler GI, Collier GR, et al. Potential regulators of feeding behavior in anorexia nervosa. Am J Clin Nutr. 1992;55:28–32.
Kinzig KP, Coughlin JW, Redgrave GW, et al. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. Am J Physiol Endocrinol Metab. 2007;292:E1441–6.
le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.
Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14:1553–61.
Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885–93.
Burton PR, Yap K, Brown WA, et al. Changes in satiety, supra- and infraband transit, and gastric emptying following laparoscopic adjustable gastric banding: a prospective follow-up study. Obes Surg. 2011;21:217–23.
de Jong JR, van Ramshorst B, Gooszen HG, et al. Weight Loss After laparoscopic adjustable gastric banding is not caused by altered gastric emptying. Obes Surg. 2009;19:287–92.